Humanized CD19 ‐targeted chimeric antigen receptor T ( CAR‐T ) cells for relapsed/refractory pediatric acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Humanized CD19 ‐targeted chimeric antigen receptor T ( CAR‐T ) cells for relapsed/refractory pediatric acute lymphoblastic leukemia

Published:2021-02-21 Issue:5 Volume:96 Page:
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Wang Shiyuan¹,Wang Xue¹,Ye Chunying¹,Cheng Hai¹,Shi Ming²,Chen Wei¹,Qi Kunming¹,Wang Gang²,Wu Qingyun³,Zeng Lingyu³,Li Zhenyu¹,Jing Guangjun⁴,Zheng Junnian²⁵⁶,Xu Kailin¹³^ORCID,Cao Jiang¹^ORCID

Affiliation:

1. Department of Hematology The Affiliated Hospital of Xuzhou Medical University Xuzhou China

2. Cancer Institute Xuzhou Medical University Xuzhou China

3. Jiangsu Bone Marrow Stem Cell Institute Xuzhou China

4. iCARTAB biomedical co. LTD Suzhou China

5. Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy Cancer Institute, Xuzhou Medical University Xuzhou China

6. Center of Clinical Oncology The Affiliated Hospital of Xuzhou Medical University Xuzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26123

Reference5 articles.

1. Acute Lymphoblastic Leukemia in Children

2. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

3. Potent anti-leukemia activities of humanized CD19-targeted Chimeric antigen receptor T (CAR-T) cells in patients with relapsed/refractory acute lymphoblastic leukemia

4. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

5. Mechanisms of resistance to CAR T cell therapy

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chimeric antigen receptor T-cell therapy in acute myeloid leukaemia: Novel therapeutic approaches to longstanding challenges;Gene Reports;2024-09

2. CD19 CAR T cells for B cell malignancies: a systematic review and meta-analysis focused on clinical impacts of CAR structural domains, manufacturing conditions, cellular product, doses, patient’s age, and tumor types;BMC Cancer;2024-08-22

3. Advances in research on factors affecting chimeric antigen receptor T‐cell efficacy;Cancer Medicine;2024-06

4. The new era of immunological treatment, last updated and future consideration of CAR T cell-based drugs;Pharmacological Research;2024-05

5. Deciphering the importance of culture pH on CD22 CAR T-cells characteristics;Journal of Translational Medicine;2024-04-24